View this record as
You are asking
What did this cost me, what is the finding, and what should happen next?
What matters to you
The recommendation, the economic classification, and the next action.
You see first
The underlying record and constitutional conclusion do not change with perspective — only what you are shown first.
Question
Why did accountability begin here, and what does the record support?
Answer
Ordinary systems can each show partial completion:
But no individual record necessarily demonstrates that all prerequisite evidence became complete, reached the treatment decision-maker, was reconciled, and supported the treatment selected.
This is not simply a missing task. It is a dependency failure.
Defensibility boundary
The record’s defensible boundary is the conclusion above. Amounts and downstream claims are not asserted where the record does not support them.
Economic impact
The supplied record asserts no economic conclusion. No amount is claimed.
Next accountable action
No distinct next accountable action is stated in this record. The defensible next step is to confirm the finding and boundary above against the accountable obligation.
Stated as a boundary because the record does not name a distinct forward action.
The same reusable structure every specialty opens into. Content is the record’s own, preserved verbatim; formal constitutional labels are inspectable at each step.
Newly diagnosed advanced non-small cell lung cancer without demonstrable completion and reconciliation of the indicated biomarker and staging prerequisites before systemic treatment selection.
This is the strongest candidate.
The pathology report provides the definitive cancer diagnosis and contributes information needed for staging and treatment planning. Biomarker testing can identify characteristics that materially affect which cancer treatments may work, while staging determines the extent of disease. (Cancer.gov)
This means the diagnosis does not create one simple downstream task. It creates several parallel and interdependent obligations.
A pathology report establishes non-small cell lung cancer.
That event creates obligations to establish the information required for treatment selection—not merely to schedule an oncology visit.
Event observed Pathology-confirmed non-small cell lung cancer.
↓
Obligation 1 — Diagnostic completeness The pathology report must contain the information needed to establish the tumor type and support subsequent testing.
Evidence: Final pathology report, specimen record, pathology addenda.
↓
Obligation 2 — Staging initiation The appropriate staging workup must be ordered and completed.
Evidence: Imaging orders, imaging reports, staging documentation.
↓
Obligation 3 — Specimen sufficiency determination The available tissue must be assessed for whether it can support indicated biomarker testing.
Evidence: Specimen adequacy statement, pathology or laboratory documentation.
↓
Obligation 4 — Biomarker testing ordered The indicated molecular and protein-marker tests must be ordered, or a documented reason must explain why they were not.
Evidence: Laboratory orders, test panel, documented contraindication or exception.
↓
Obligation 5 — Testing accepted and performed The receiving laboratory must accept the specimen, complete testing, and report failures, insufficiency, or required recollection.
Evidence: Laboratory accession, rejection notice, result report, test-failure report.
↓
Obligation 6 — Results reconciled Staging, pathology, and biomarker results must be assembled into a complete decision record.
Evidence: Oncology note, tumor-board record, structured treatment-planning record.
↓
Obligation 7 — Treatment selected The treatment plan must be supported by the completed evidence—or the record must document why treatment began before every expected result was available.
Evidence: Treatment decision, clinical rationale, orders and consent.
↓
Obligation 8 — Treatment initiation verified Ordering a treatment does not demonstrate that it occurred.
Evidence: Administration record, pharmacy release, infusion record, oral-therapy receipt.
The existing system
The record does not separately enumerate conventional-system visibility for this specialty. What The Engine reveals is shown alongside.
The Engine
Ordinary systems can each show partial completion:
But no individual record necessarily demonstrates that all prerequisite evidence became complete, reached the treatment decision-maker, was reconciled, and supported the treatment selected.
This is not simply a missing task. It is a dependency failure.
Evidence-dependent obligation gating
Some obligations should not be treated as ready for execution until prerequisite facts exist and have been verified.
The Engine must be capable of demonstrating:
That is meaningfully different from the four properties already approved.
Important constraint
The Engine must not independently decide which cancer treatment was clinically correct.
It can determine whether:
Clinical appropriateness remains a matter for qualified clinicians and the applicable standards. The Engine demonstrates the accountability surrounding the decision.
Ordinary systems can each show partial completion:
But no individual record necessarily demonstrates that all prerequisite evidence became complete, reached the treatment decision-maker, was reconciled, and supported the treatment selected.
This is not simply a missing task. It is a dependency failure.